2020
Intrinsic reward circuit connectivity profiles underlying symptom and quality of life outcomes following antidepressant medication: a report from the iSPOT-D trial
Fischer AS, Holt-Gosselin B, Fleming SL, Hack LM, Ball TM, Schatzberg AF, Williams LM. Intrinsic reward circuit connectivity profiles underlying symptom and quality of life outcomes following antidepressant medication: a report from the iSPOT-D trial. Neuropsychopharmacology 2020, 46: 809-819. PMID: 33230268, PMCID: PMC8027440, DOI: 10.1038/s41386-020-00905-3.Peer-Reviewed Original ResearchConceptsMajor depressive disorderISPOT-D TrialReward neurocircuitryFunctional connectivitySymptom respondersQOL responsesAntidepressant medication responseFC relativeQuality of lifeSame time pointsNeural basisAntidepressant medicationVenlafaxine XRSymptom responseDepressive disorderHealthy controlsMedication responseSymptom alleviationADM treatmentADM responsesLife outcomesNeurocircuitrySymptomsTime pointsConnectivity profiles
2010
Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes
Joffe H, Partridge A, Giobbie-Hurder A, Li X, Habin K, Goss P, Winer E, Garber J. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes. Menopause The Journal Of The North American Menopause Society 2010, 17: 908-916. PMID: 20581724, DOI: 10.1097/gme.0b013e3181dbee1b.Peer-Reviewed Original ResearchMeSH KeywordsAdultBreast NeoplasmsChemotherapy, AdjuvantCyclohexanolsDouble-Blind MethodDrug Therapy, CombinationFemaleHot FlashesHumansHypnotics and SedativesMiddle AgedPlacebosPyridinesQuality of LifeSelective Serotonin Reuptake InhibitorsSleep Disorders, IntrinsicVenlafaxine HydrochlorideZolpidemConceptsSerotonin-norepinephrine reuptake inhibitorsSelective serotonin reuptake inhibitorsQuality of lifeSSRIs/serotonin-norepinephrine reuptake inhibitorsSerotonin reuptake inhibitorsBreast cancer survivorsHot flashesReuptake inhibitorsCancer survivorsHypnotic agentsSSRI/SNRI therapySSRI/SNRI usersNighttime hot flashesAdjuvant endocrine therapyAssociated sleep disturbancesBreast cancer patientsProportion of respondersSubjective sleep qualitySNRI therapySNRI usersBlinded treatmentEndocrine therapyPlacebo augmentationVenlafaxine XRNocturnal awakenings
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply